Announcements Trials
Browse Landscape

Phase

Phase 1 5Phase 2 2Phase NA 1Phase EARLY_PHASE1 1Phase 3 1Phase 1/2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 276Other hematologic neoplasm 167Plasma cell 129Gynecologic 83Sarcoma 76Head & Neck 66Myeloid 56CNS 55Dermatologic 40Gastrointestinal 36Genitourinary 32Thoracic 27Breast 23Classical hematology 16Endocrine 5Other neoplasm 4Other solid neoplasm 2NET 2Other 1

Conditions

Mesothelioma, Malignant 120Mesothelioma 70Solid Tumor 46Solid Tumors 33Retinoblastoma 27Solitary Fibrous Tumor, Pleural 20Sarcoma 17Advanced Solid Tumor 16Advanced Solid Tumors 15Lung Neoplasms 13Small Cell Lung Carcinoma 12Carcinoma, Non-Small-Cell Lung 11Osteosarcoma 9Neuroblastoma 8Ovarian Neoplasms 7Unspecified Adult Solid Tumor, Protocol Specific 6Solid Tumor, Adult 6Colorectal Neoplasms 6Cholangiocarcinoma 6Central Nervous System Neoplasms 6Carcinoma, Renal Cell 6Uterine Cervical Neoplasms 5Thyroid Neoplasms 5Stomach Neoplasms 5Neoplasms 5Melanoma 5Medulloblastoma 5Chondrosarcoma 5Carcinoma, Hepatocellular 5Breast Neoplasms 5

Interventions

vandetanib 1niraparib 1Vinorelbine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Recurrence × Other solid neoplasm × Clear all
NCT05455424 2025-05-15

NERO

University Hospital Southampton NHS Foundation Trust

Phase 2 Completed
88 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma, Recurrence

NCT00597116 2016-10-10

An Efficacy and Safety Study With Vandetanib to Treat Inoperable or Relapsed Malignant Mesothelioma

Sanofi

Phase 2 Terminated
25 enrolled 8 charts
Other solid neoplasmThoracic

Mesothelioma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡